No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:113629200-113643200 |
Weak transcription |
Right Atrium |
heart
|
2 |
chr2:113632800-113641600 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
3 |
chr2:113632800-113644400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
4 |
chr2:113633000-113640600 |
Enhancers |
HMEC |
breast
|
5 |
chr2:113634000-113640200 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
6 |
chr2:113635000-113638000 |
Weak transcription |
Brain Inferior Temporal Lobe |
brain
|
7 |
chr2:113635400-113638200 |
Enhancers |
NHEK |
skin
|
8 |
chr2:113635800-113638000 |
Weak transcription |
HSMMtube |
muscle
|
9 |
chr2:113636400-113639200 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
10 |
chr2:113636400-113640400 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
11 |
chr2:113636600-113638000 |
Weak transcription |
Brain Angular Gyrus |
brain
|
12 |
chr2:113636600-113638600 |
Enhancers |
Fetal Thymus |
thymus
|
13 |
chr2:113636600-113638800 |
Enhancers |
GM12878-XiMat |
blood
|
14 |
chr2:113636800-113639600 |
Bivalent Enhancer |
HepG2 |
liver
|
15 |
chr2:113636800-113640000 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
16 |
chr2:113636800-113640200 |
Enhancers |
NHDF-Ad |
bronchial
|
17 |
chr2:113637000-113638200 |
Enhancers |
Lung |
lung
|
18 |
chr2:113637000-113639000 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
19 |
chr2:113637000-113639600 |
Enhancers |
Hela-S3 |
cervix
|
20 |
chr2:113637000-113640000 |
Enhancers |
Brain Hippocampus Middle |
brain
|
21 |
chr2:113637000-113643600 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
22 |
chr2:113637200-113639000 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
23 |
chr2:113637200-113639200 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
24 |
chr2:113637200-113639200 |
Enhancers |
Primary B cells from peripheral blood |
blood
|
25 |
chr2:113637200-113639200 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
26 |
chr2:113637200-113639600 |
Enhancers |
NH-A |
brain
|
27 |
chr2:113637200-113640400 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
28 |
chr2:113637400-113639400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
29 |
chr2:113637400-113639400 |
Enhancers |
HSMM |
muscle
|
30 |
chr2:113637400-113639600 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
31 |
chr2:113637400-113639800 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
32 |
chr2:113637400-113640000 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
33 |
chr2:113637400-113640000 |
Enhancers |
Osteobl |
bone
|
34 |
chr2:113637600-113638200 |
Enhancers |
Spleen |
Spleen
|
35 |
chr2:113637600-113639600 |
Enhancers |
HUVEC |
blood vessel
|
36 |
chr2:113637600-113640000 |
Enhancers |
Brain Anterior Caudate |
brain
|
37 |
chr2:113637800-113638000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
38 |
chr2:113637800-113638000 |
Weak transcription |
Pancreas |
Pancrea
|
39 |
chr2:113637800-113638200 |
Enhancers |
Esophagus |
oesophagus
|
40 |
chr2:113637800-113638600 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
41 |
chr2:113637800-113639200 |
Enhancers |
Adipose Nuclei |
Adipose
|
42 |
chr2:113637800-113639200 |
Enhancers |
NHLF |
lung
|
43 |
chr2:113637800-113639400 |
Enhancers |
Brain Dorsolateral Prefrontal Cortex |
brain
|
44 |
chr2:113637800-113639600 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
45 |
chr2:113637800-113639800 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
46 |
chr2:113637800-113639800 |
Enhancers |
Brain Cingulate Gyrus |
brain
|